Predict your next investment

INDUSTRIAL
creare.com

See what CB Insights has to offer

Stage

Grant - XVIII | Alive

About Creare

Creare Incorporated is a Hanover, NH based company that has received a grant(s) from the Department of Energy's SBIR/STTR program. The abstract(s) for these grant award(s) are provided as well since they provide insights into Creare Incorporated's business and areas of expertise. This project will develop a system to model and analyze the wall erosion on the Spallation Neutron Source target at Oak Ridge National Laboratory. This system will enable the materials science research facility to operate at higher efficiency.

Creare Headquarter Location

P.O. Box 71 P.O. Box 71

Hanover, New Hampshire, 03755,

United States

603-643-3800

Latest Creare News

Creare siti web ecologici con data center green e design sostenibile

Mar 31, 2021

Anche un sito web aziendale ha un impatto ambientale, che si può ridurre con benefici anche per il conto economico: ne abbiamo parlato in una videointervista con Seeweb e Piano D Di Chiara Grande, responsabile marketing di Seeweb Lo sviluppo sostenibile e il rispetto dell’ambiente sono ormai stabilmente temi di primo piano non solo a livello di singoli consumatori ma anche delle aziende, che sono tenute a certificazioni ambientali e obblighi normativi, tra cui da qualche anno la redazione di un bilancio di sostenibilità. Detto questo, Computerworld si occupa di tecnologie digitali, e difficilmente si pensa a questo settore in termini di impatto ambientale. E invece dobbiamo iniziare a parlarne: lo stesso ministro della transizione ecologica Roberto Cingolani ha detto che il digitale è un insieme di tecnologie fantastiche, ma che inquinano il doppio del trasporto aereo in quanto a emissioni di CO2. Nicola Bonotto, cofondatore e responsabile produzione di Piano D In questa videointervista, abbiamo parlato di come migliorare la sostenibilità dei siti web – con benefici sia per l’ambiente che per il conto economico aziendale – con Chiara Grande, responsabile marketing di Seeweb, e con Nicola Bonotto, co-fondatore e responsabile della produzione di Piano D. adv

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Creare Patents

Creare has filed 21 patents.

The 3 most popular patent topics include:

  • Drug delivery devices
  • Medical equipment
  • Dosage forms
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/3/2014

3/24/2020

Drug delivery devices, Medical equipment, Dosage forms, Optical devices, Respiratory therapy

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/3/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/24/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Drug delivery devices, Medical equipment, Dosage forms, Optical devices, Respiratory therapy

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Creare Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Creare Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.